Garvican, L and Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X
(2004)
A pilot quality assurance scheme for diabetic retinopathy risk reduction programmes.
Diabetic Medicine, 21 (10).
pp. 1066-1074.
doi:10.1111/j.1464-5491.2004.01300.x
Harding, S, Greenwood, R, Aldington, S, Gibson, J, Owens, D, Taylor, R, Kohner, E, Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X and Leese, G
(2003)
Grading and disease management in national screening for diabetic retinopathy in England and Wales.
Diabetic Medicine, 20 (12).
pp. 965-971.
doi:10.1111/j.1464-5491.2003.01077.x
Moreton, R B, Stratton, I M, Chave, S J, Lipinski, H and Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X
(2017)
Factors determining uptake of diabetic retinopathy screening in Oxfordshire.
Diabetic Medicine, 34 (7).
pp. 993-999.
doi:10.1111/dme.13350
Oke, J L, Stratton, I M, Aldington, S J, Stevens, R J and Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X
(2016)
The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme.
Diabetic Medicine, 33 (7).
pp. 896-903.
doi:10.1111/dme.13053
Sallam, A, Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Stratton, I M, Jones, V, Martin, C N, Brelen, M and Johnston, R L
(2011)
Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy.
Diabetic Medicine, 28 (6).
pp. 741-746.
doi:10.1111/j.1464-5491.2011.03273.x
Scanlon, P. H. ORCID: https://orcid.org/0000-0001-8513-710X, Norridge, C. F. E.
ORCID: https://orcid.org/0000-0002-4548-3902, Prentis, D., Holman, N.
ORCID: https://orcid.org/0000-0002-7432-5786, Rankin, P. and Valabhji, J.
ORCID: https://orcid.org/0000-0001-9756-4061
(2025)
Effect of the COVID ‐19 pandemic on diabetic retinopathy and referral levels in the English National Health Service Diabetic Eye Screening Programme.
Diabetic Medicine.
doi:10.1111/dme.15518
(In Press)
Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X
(2012)
The preferences of people with diabetes for diabetic retinopathy screening.
Diabetic Medicine, 29 (7).
pp. 836-837.
doi:10.1111/j.1464-5491.2012.03630.x
Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Aldington, S. J. and Stratton, I. M.
(2013)
Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.
Diabetic Medicine, 31 (4).
pp. 439-442.
doi:10.1111/dme.12313
Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Loftus, J, Starita, C. and Stratton, I M
(2015)
The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial.
Diabetic Medicine, 32 (1).
pp. 97-101.
doi:10.1111/dme.12593
Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Malhotra, R, Thomas, G, Foy, C, Kirkpatrick, J N, Lewis-Barned, N, Harney, B and Aldington, S J
(2003)
The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy.
Diabetic Medicine, 20 (6).
pp. 467-474.
Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Martin, M. L., Bailey, C., Johnson, E., Hykin, P. and Keightley, S.
(2006)
Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy.
Diabetic Medicine, 23 (1).
pp. 60-66.
doi:10.1111/j.1464-5491.2005.01736.x
Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Stratton, I M, Leese, G P, Bachmann, M O, Land, M, Jones, C and Ferguson, B
(2016)
Screening attendance, age group and diabetic retinopathy level at first screen.
Diabetic Medicine, 33 (7).
pp. 904-911.
doi:10.1111/dme.12957
Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Stratton, I. M., Bachmann, M. O., Jones, C. and Leese, G. P.
(2016)
Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.
Diabetic Medicine, 33 (12).
pp. 1655-1658.
doi:10.1111/dme.13263
Smith, J.J., Wright, D.M., Scanlon, Peter H. ORCID: https://orcid.org/0000-0001-8513-710X and Lois, N.
(2020)
Risk Factors Associated with Progression to Referable Retinopathy: A Type 2 Diabetes Mellitus Cohort Study in the Republic of Ireland.
Diabetic Medicine, 37 (6).
pp. 1000-1007.
doi:10.1111/dme.14278
West, S D, Groves, D C, Lipinski, H J, Nicoll, D J, Mason, R H, Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X and Stradling, J R
(2010)
The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea.
Diabetic Medicine, 27 (4).
pp. 423-430.
doi:10.1111/j.1464-5491.2010.02962.x